A detailed history of Raymond James Financial Inc transactions in Stryker Corp stock. As of the latest transaction made, Raymond James Financial Inc holds 952,809 shares of SYK stock, worth $343 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares
952,809
Previous 978,823 2.66%
Holding current value
$343 Million
Previous $387 Million 9.05%
% of portfolio
0.12%
Previous 0.14%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025

SELL
$368.57 - $403.53 $9.59 Million - $10.5 Million
-26,014 Reduced 2.66%
952,809 $352 Million
Q2 2025

Aug 14, 2025

BUY
$337.37 - $395.63 $256,063 - $300,283
759 Added 0.08%
978,823 $387 Million
Q1 2025

May 13, 2025

SELL
$355.18 - $399.9 $1.22 Million - $1.38 Million
-3,448 Reduced 0.35%
978,064 $364 Million
Q4 2024

Apr 23, 2025

SELL
$345.14 - $392.15 $345 - $392
-1 Reduced -0.0%
981,512 $353 Million
Q4 2024

Feb 06, 2025

BUY
$345.14 - $392.15 $339 Million - $385 Million
981,513 New
981,513 $353 Million

Others Institutions Holding SYK

About STRYKER CORP


  • Ticker SYK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 378,320,992
  • Market Cap $136B
  • Description
  • Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products c...
More about SYK
Track This Portfolio

Track Raymond James Financial Inc Portfolio

Follow Raymond James Financial Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Raymond James Financial Inc with notifications on news.